Long-term Outcome of the Milano-Hyperfractionated Accelerated Radiotherapy Strategy for High-Risk Medulloblastoma, Including the Impact of Molecular Subtype

Medicine, Neurology, Neurosurgery, Oncology,
high-risk medulloblastoma   hyperfractionated accelerated radiotherapy   molecular subtype   chemotherapy response   long-term survival  

Long-Term Outcomes of High-Risk Medulloblastoma Treatment Background Medulloblastoma is one of the most common malignant brain tumors in children. Despite advancements in treatment, the prognosis for high-risk medulloblastoma patients remains poor. High-risk medulloblastoma typically includes patients with metastatic disease, TP53 mutations, MYC/MY...

Proteomic Stratification of Prognosis and Treatment Options for Small Cell Lung Cancer

Medicine, Oncology, Life Sciences, Cell Biology, Biochemistry, Immunology,
small cell lung cancer   proteomics   prognosis   chemotherapy response   immunotherapy  

Proteomic Subtyping of Small Cell Lung Cancer: Analysis of Prognosis and Treatment Strategies Research Background Small Cell Lung Cancer (SCLC) is a highly malignant and heterogeneous cancer characterized by rapid growth, early metastasis, and drug resistance, which limits treatment options and challenges prognostic prediction models. Current genom...